What Clinicians Want to Know: Understanding the Factors Impacting the Optimal Diagnosis and Management of Ovarian Cancer
February 18th at 5 PM ET
Register at: https://www.researchtopractice.com/Webinars/OvarianCancer2021/Feb18
Join Dr Neil Love February 18th at 5 PM ET as he is joined by gynecologic oncology clinical investigators Drs Michael Birrer, Kathleen Moore and David O’Malley to discuss the diagnosis and management of patients with ovarian cancer with .
To bring in the perspectives of the entire care management team, we recorded several nurse practitioners who reviewed particularly challenging cases from their practice to be presented to our faculty panel. By utilizing real world cases in our program, we hope to create an educational program for all members of the healthcare team who play a vital role in a patient’s ovarian cancer diagnosis and preparation for their journey through treatment.
Topics to be discussed:
· Biology of ovarian cancer (OC); incidence and relevance of various germline and somatic genomic abnormalities
· Indications for and practical implementation of genetic testing for patients with newly diagnosed advanced OC
· Current role of PARP inhibitor maintenance therapy in the first-line setting for patients with advanced OC with and without BRCA mutations
· Identification and management of side effects and other practical considerations with the use of PARP inhibitors in advanced OC